Literature DB >> 11733503

Effects of B-Myb on gene transcription: phosphorylation-dependent activity ans acetylation by p300.

Lance R Johnson1, Teresa K Johnson, Michelle Desler, Troy A Luster, Tamara Nowling, Robert E Lewis, Angie Rizzino.   

Abstract

The transcription factor B-Myb is a cell-cycle regulated phosphoprotein involved in cell cycle progression through the transcriptional regulation of many genes. In this study, we show that the promoter of the fibroblast growth factor-4 (FGF-4) gene is strongly activated by B-Myb in HeLa cells and it can serve as a novel diagnostic tool for assessing B-Myb activity. Specifically, B-Myb deletion mutants were examined and domains of B-Myb required for activation of the FGF-4 promoter were identified. Using phosphorylation-deficient mutant forms of B-Myb, we also show that phosphorylation is essential for B-Myb activity. Moreover, a mutant form of B-Myb, which lacks all identified phosphorylation sites and which has little activity, can function as a dominant-negative and suppress wild-type B-Myb activity. Acetylation is another post-translational modification known to affect the activity of other Myb family members. We show that B-Myb is acetylated by the co-activator p300. We also show that the bromo and histone acetyltransferase domains of p300 are sufficient to interact with and acetylate B-Myb. These data indicate that phosphorylation of B-Myb is an essential modification for activity and that acetylation of B-Myb may play a role in B-Myb activity.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11733503     DOI: 10.1074/jbc.M105112200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression.

Authors:  Subhashini Sadasivam; Shenghua Duan; James A DeCaprio
Journal:  Genes Dev       Date:  2012-03-01       Impact factor: 11.361

2.  NF-Y behaves as a bifunctional transcription factor that can stimulate or repress the FGF-4 promoter in an enhancer-dependent manner.

Authors:  Cory T Bernadt; Tamara Nowling; Matthew S Wiebe; Angie Rizzino
Journal:  Gene Expr       Date:  2005

3.  The human synMuv-like protein LIN-9 is required for transcription of G2/M genes and for entry into mitosis.

Authors:  Lisa Osterloh; Björn von Eyss; Fabienne Schmit; Lena Rein; Denise Hübner; Birgit Samans; Stefanie Hauser; Stefan Gaubatz
Journal:  EMBO J       Date:  2006-12-07       Impact factor: 11.598

4.  Conservation of epigenetic regulation, ORC binding and developmental timing of DNA replication origins in the genus Drosophila.

Authors:  B R Calvi; B A Byrnes; A J Kolpakas
Journal:  Genetics       Date:  2007-11       Impact factor: 4.562

Review 5.  Stem cell pluripotency: a cellular trait that depends on transcription factors, chromatin state and a checkpoint deficient cell cycle.

Authors:  Kenneth R Boheler
Journal:  J Cell Physiol       Date:  2009-10       Impact factor: 6.384

Review 6.  B-Myb, cancer, senescence, and microRNAs.

Authors:  Ivan Martinez; Daniel Dimaio
Journal:  Cancer Res       Date:  2011-08-09       Impact factor: 12.701

7.  B-Myb promotes S-phase independently of its sequence-specific DNA binding activity and interacts with polymerase delta-interacting protein 1 (Pdip1).

Authors:  Eugen Werwein; Thore Schmedt; Heiko Hoffmann; Clemens Usadel; Nora Obermann; Jeffrey D Singer; Karl-Heinz Klempnauer
Journal:  Cell Cycle       Date:  2012-10-03       Impact factor: 4.534

8.  Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu.

Authors:  Apollina Goel; Ralf Janknecht
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

9.  B-Myb acts as a repressor of human COL1A1 collagen gene expression by interacting with Sp1 and CBF factors in scleroderma fibroblasts.

Authors:  Lucia Cicchillitti; Sergio A Jimenez; Arturo Sala; Biagio Saitta
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

Review 10.  The molecular balancing act of p16(INK4a) in cancer and aging.

Authors:  Kyle M LaPak; Christin E Burd
Journal:  Mol Cancer Res       Date:  2013-10-17       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.